178 reports across 5 categories, with market size and growth to 2033.
2023–2033 CAGR · estimates
Market size in 2023
Active trials (recruiting, about to start or running) in Brazil, Mexico, Ecuador
| Measure | Brazil | Mexico | Ecuador |
|---|---|---|---|
| Diabetes (adults) % of adults | 12.9 2022 | 14.3 2022 | 12.7 2022 |
| Obesity (adults) % of adults | 30.1 2024 | 37.4 2024 | 28.9 2024 |
| High blood pressure (ages 30–79) % of adults 30–79 | 45.0 2019 | 32.1 2019 | 27.2 2019 |
| Anaemia in women 15–49 % of women | 21.3 2023 | 13.2 2023 | 20.2 2023 |
| Universal health coverage index index (0–100) | 84 2023 | 79 2023 | 78 2023 |
| Road traffic deaths per 100,000 people | 15.4 2023 | 11.2 2023 | 19.8 2023 |
| Healthy life expectancy years | 63.8 2023 | 63.1 2023 | 66.5 2023 |
| Early deaths from long-term diseases % | 14.6 2023 | 15.4 2023 | 10.5 2023 |
| Tobacco use (adults) % of adults | 11.5 2025 | 15.6 2025 | 10.0 2025 |
| Not active enough (adults) % of adults | 40.4 2022 | 28.0 2022 | 22.8 2022 |
| Alcohol drunk per person litres of pure alcohol (15+) | 10.4 2024 | 6.7 2024 | 3.2 2024 |
| Fine dust in the air (PM2.5) µg per m³ | 20.4 2023 | 16.1 2023 | 8.1 2023 |
| Measure | Brazil | Mexico | Ecuador |
|---|---|---|---|
| Population people | 212.8 million 2025 | 131.9 million 2025 | 18.3 million 2025 |
| Life expectancy at birth years | 76.0 2024 | 75.3 2024 | 77.6 2024 |
| People aged 65 and over % of people | 11.5 2025 | 8.5 2025 | 8.6 2025 |
| Health spending per person US$ per person | 1,010 2023 | 761 2023 | 509 2023 |
| Health spending (% of GDP) % of GDP | 9.7 2023 | 5.5 2023 | 7.6 2023 |
| Out-of-pocket spending % of health spending | 26.2 2023 | 41.2 2023 | 30.9 2023 |
| Doctors per 1,000 people | 2.36 2023 | 2.59 2022 | 2.31 2020 |
| Nurses and midwives per 1,000 people | 5.50 2023 | 3.03 2022 | 2.51 2018 |
| Hospital beds per 1,000 people | 2.52 2021 | 1.01 2022 | 1.32 2023 |
Medtronic30 reports
Johnson & Johnson27 reports
Abbott Laboratories25 reports
Pfizer Inc.24 reports
GE Healthcare23 reports
Siemens Healthineers21 reports
Novartis AG19 reports
Philips Healthcare16 reports
Merck & Co., Inc.15 reports
Sanofi15 reports
Bayer AG15 reports
IBM Watson Health13 reports
Each market name opens its Latin America report. To compare one market across every country, see market statistics.
| Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|
| Alopecia areata | – | – | – | 10 |
| Alzheimers Dignostic | $95 Mn | $202 Mn | 7.9% | 24 |
| Ambulance Service | $1.4 Bn | $3.1 Bn | 8.1% | 97 |
| Ambulatory Surgery Center | $1.8 Bn | $3.6 Bn | 7.1% | 597 |
| Antimicrobial Susceptibility Testing | – | – | – | 1 |
| Bioinformatics | $549 Mn | $2.3 Bn | 15.4% | 2 |
| Biomaterial Wound Dressing | $369 Mn | $775 Mn | 7.7% | 5 |
| Blood Gas and Electrolyte Analyzers | $126 Mn | $257 Mn | 7.4% | 29 |
| Bone Cancer Diagnostic | $50 Mn | $111 Mn | 8.4% | 30 |
| Brain Cancer Diagnostic | $68 Mn | $264 Mn | 14.6% | 33 |
| Breast Cancer Diagnostic | $185 Mn | $429 Mn | 8.8% | 177 |
| Clinical Laboratory Service | – | – | – | 399 |
| Dental Care Service | – | – | – | 19 |
| Dental Imaging | $153 Mn | $359 Mn | 8.9% | 19 |
| Dermatology Diagnostic | $1.2 Bn | $3.7 Bn | 12.2% | 188 |
| Fertility Service | $945 Mn | $1.9 Bn | 7.1% | 5 |
| Healthcare Electronic Data Interchange (EDI) | $180 Mn | $484 Mn | 10.4% | 7 |
| Healthcare In Vitro Diagnostic | $3.8 Bn | $6 Bn | 4.8% | 6 |
| Hospitals and Health Systems | $196 Bn | $371.5 Bn | 6.6% | 2,105 |
| Medical Billing | $203 Mn | $652 Mn | 12.4% | 3 |
| Medical Tourism | $3.3 Bn | $11.5 Bn | 13.2% | 1 |
| Nursing Education | $464 Mn | $1.1 Bn | 9.1% | 9 |
| Patient Support Programs (PSP) | $774 Mn | $2.7 Bn | 16.8% | 40 |
| Point Of Care (PoC) Molecular Diagnostic | $842 Mn | $2.2 Bn | 10.3% | 138 |
| Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|
| Acute Care Needleless Connectors | $22 Mn | $50 Mn | 8.5% | – |
| Advanced Bipolar Direct Energy Devices | $140 Mn | $352 Mn | 9.7% | – |
| Aesthetic Lasers and Energy Devices | $73 Mn | $250 Mn | 13.1% | – |
| Air Ambulance Life Support Solutions | $201 Mn | $527 Mn | 10.1% | – |
| Airway Management Devices | $90 Mn | $164 Mn | 6.2% | – |
| Anastomosis Devices | $142 Mn | $300 Mn | 7.8% | – |
| Anesthesia & Respiratory Devices | $1.3 Bn | $3.5 Bn | 10.5% | – |
| Anesthesia Monitoring Devices | $119 Mn | $422 Mn | 13.5% | – |
| Angiography Devices | $560 Mn | $1.1 Bn | 7.3% | – |
| Angioplasty Balloons | $183 Mn | $292 Mn | 4.8% | – |
| Anti-Snoring Devices | $56 Mn | $143 Mn | 9.8% | – |
| Apheresis Equipments | $114 Mn | $229 Mn | 7.2% | – |
| Arrhythmia Monitoring Devices | $270 Mn | $508 Mn | 6.5% | – |
| Assisted Walking Aids | $104 Mn | $194 Mn | 6.5% | – |
| Audiology Devices | $352 Mn | $720 Mn | 7.4% | – |
| Defibrillator | $798 Mn | $1.6 Bn | 6.9% | – |
| Dental Articulators | $18 Mn | $36 Mn | 7.4% | – |
| Dental Caries Detectors | $17 Mn | $56 Mn | 12.8% | – |
| Dental Diagnostic and Surgical Equipments | $539 Mn | $1.2 Bn | 8.1% | – |
| Dental X-Ray Equipments | $79 Mn | $173 Mn | 8.2% | – |
| Diabetes Care Devices | $1.9 Bn | $3.7 Bn | 6.9% | 22 |
| Digital Diabetes Management | – | – | – | – |
| Direct Energy Medical Devices | $497 Mn | $890 Mn | 6% | – |
| Disposable Surgical Devices | $407 Mn | $903 Mn | 8.3% | – |
| Insulin Delivery Devices | $715 Mn | $1.5 Bn | 7.5% | – |
| Insulin Patch Pumps | $40 Mn | $136 Mn | 13% | – |
| Rehabilitation Equipments | $901 Mn | $1.8 Bn | 7.1% | – |
"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.
Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.